Investigating Reactivation of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Menopausal Women
Who is this study for? Older adult female patients with Anovulatory Infertility
What treatments are being studied? Autologous PRP Intra-Ovarian Infusion
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY
Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 45
Maximum Age: 55
Healthy Volunteers: t
View:
• Age between 45-55 years old
• Amenorrhea for at least 12 months
• Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment.
• Willing to comply with study requirements
Locations
Other Locations
Greece
Genesis AC
RECRUITING
Athens
Contact Information
Primary
Mara Simopoulou, PhD
marasimopoulou@hotmail.com
+306979234100
Backup
Agni Pantou, MD
agni.pantou@genesisathens.gr
+306974447702
Time Frame
Start Date: 2019-05-21
Estimated Completion Date: 2026-07-30
Participants
Target number of participants: 100
Treatments
Experimental: Participants receiving PRP treatment
Menopausal women minimum 45 years of age, receiving ovarian PRP treatment.
Placebo_comparator: Control Group: Participants receiving Platelet Free Plasma
Women in menopause, 45-55 years old, treated with autologous PFP intra ovarian infusion.
Related Therapeutic Areas
Sponsors
Collaborators: National and Kapodistrian University of Athens
Leads: Genesis Athens Clinic